Literature DB >> 1646592

Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.

C Letellier1, A Burny, G Meulemans.   

Abstract

A pigeonpox transfer plasmid was constructed by cloning a 2.5 kb DNA fragment containing the viral thymidine kinase (TK) gene in the psp65 plasmid. The vaccinia virus P11K promoter followed by the NDV fusion (F) gene was inserted in the TK gene. The F gene was transferred to the viral genome by homologous recombination in pigeonpox virus infected CEF cells, transfected with the recombinant plasmid. Recombinant viruses were selected with BUdR and screened for their ability to induce fusion between adjacent cells. Because of the unexpected growth advantage of the TK+ WT over the TK- recombinants, viral purification was needed to obtain stable recombinants expressing a glycosylated and cleaved F protein. Vaccination of chickens by the follicular method induced high anti-F antibody titers and good protection against challenge with the virulent Italian NDV strain. Half of the oculonasal vaccinated chickens showed anti F antibodies and also half of them were protected. Although protection seems to be correlated with antibody titers, no neutralizing antibodies were found.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646592     DOI: 10.1007/bf01311302

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus.

Authors:  T Barrett; G J Belsham; S M Subbarao; S A Evans
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

2.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

3.  Identification and cloning of the fowlpox virus thymidine kinase gene using vaccinia virus.

Authors:  D B Boyle; B E Coupar
Journal:  J Gen Virol       Date:  1986-08       Impact factor: 3.891

4.  Construction of recombinant fowlpox viruses as vectors for poultry vaccines.

Authors:  D B Boyle; B E Coupar
Journal:  Virus Res       Date:  1988-06       Impact factor: 3.303

5.  Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

Authors:  R A Olmsted; N Elango; G A Prince; B R Murphy; P R Johnson; B Moss; R M Chanock; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Genetic and biochemical characterization of the thymidine kinase gene from herpesvirus of turkeys.

Authors:  S L Martin; D I Aparisio; P K Bandyopadhyay
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  Expression at the cell surface of native fusion protein of the Newcastle disease virus (NDV) strain Italien from cloned cDNA.

Authors:  D Espion; S de Henau; C Letellier; C D Wemers; R Brasseur; J F Young; M Gross; M Rosenberg; G Meulemans; A Burny
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice.

Authors:  M E Andrew; B E Coupar
Journal:  Scand J Immunol       Date:  1988-07       Impact factor: 3.487

9.  Genomic and antigenic characterization of avipoxviruses.

Authors:  W M Schnitzlein; N Ghildyal; D N Tripathy
Journal:  Virus Res       Date:  1988-04       Impact factor: 3.303

Review 10.  Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.

Authors:  D C Merz; A Scheid; P W Choppin
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens.

Authors:  J G Calvert; K Nazerian; R L Witter; N Yanagida
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 4.  Viral vectors for veterinary vaccines.

Authors:  M Sheppard
Journal:  Adv Vet Med       Date:  1999

Review 5.  Recombinant fowlpox virus vaccines for poultry.

Authors:  D B Boyle; H G Heine
Journal:  Immunol Cell Biol       Date:  1993-10       Impact factor: 5.126

6.  Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain.

Authors:  Woo-Jin Jeon; Eun-Kyoung Lee; Young-Jeong Lee; Ok-Mi Jeong; Yong-Joo Kim; Jun-Hun Kwon; Kang-Seuk Choi
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

Review 7.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

Review 8.  Recent advances in avian virology.

Authors:  D Cavanagh
Journal:  Br Vet J       Date:  1992 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.